Subgingival Instrumentation
Subgingival Instrumentation
Subgingival Instrumentation
Subgingival Instrumentation
for Treatment of Periodontitis.
A Systematic Review.
Suvan, J1, Leira Y1, Moreno F1, Graziani F2, Derks J3, Tomasi C3
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1111/JCPE.13245
This article is protected by copyright. All rights reserved
Corresponding Author:
Accepted Article
Cristiano Tomasi
Department of Periodontology
Institute of Odontology
The Sahlgrenska Academy at University of Gothenburg
Box 450
SE 405 30 Gothenburg
Sweden
E-mail: cristiano.tomasi@odontologi.gu.se
Abstract
The main goal of the treatment of patients suffering from periodontitis is the establishment of
adequate infection control, i.e. reduction of the bacterial load below individual threshold levels of
inflammation/disease. Health behaviour strategies to facilitate patient motivation targeting high-
level self-performed supra-gingival plaque control and management of lifestyle habits such as
smoking are key in addressing the vital patient role in non-surgical therapy (Ramseier & Suvan,
2015). Supplemental to patient self-care, subgingival instrumentation serves the purpose of
altering the subgingival ecological environment through disruption of the microbial biofilm and
removal of hard deposits, i.e. periodontal debridement, thereby suppressing soft tissue
inflammation (Heitz-Mayfield & Lang, 2013; Jepsen, Deschner, Braun, Schwarz & Eberhard,
2011). A reasonable endpoint of non-surgical treatment should include shallow pocket depth (PD)
and absence of clinical signs of inflammation, i.e. oedema and bleeding on probing (BOP).
Nevertheless, mean values of probing pocket depth reduction and clinical attachment gain are the
most commonly reported outcomes in studies. An ideal endpoint of therapy, however, should be
clinically meaningful with tangible benefits for the patient. Endpoints must also be considered in
relation to the goal of therapy. The question of the most adequate outcomes to evaluate non-
surgical periodontal therapy has been discussed in the literature (Hujoel, 2004; Tomasi &
Wennström, 2017).
The efficacy (as established in strictly defined research setting to minimise confounding factors)
of nonsurgical subgingival instrumentation as part of periodontal treatment is well documented
and has been summarized in several reviews (Hallmon & Rees, 2003; Herrera, 2016; Smiley et
al., 2015; Suvan, 2005; Tomasi & Wennström, 2009; Tunkel, Heinecke, & Flemmig, 2002; Van
Another objective of this review is to evaluate the potential impact of mode of delivery of
subgingival instrumentation without adjunctive antiseptics. Traditionally, sessions for mechanical
instrumentation were scheduled with intervals of one week between appointments in order to
instrument one segment of the entire dentition. This staged treatment approach allows for
meticulous treatment of the target sites with the possibility for repeated re-enforcement of
patients’ self-performed infection control. An alternative to the conventional approach, a full-
mouth instrumentation protocol, was first described by Quirynen and co-workers in 1995 and
comprised two sessions of scaling and root planing within 24 hours with the use of adjunctive
antiseptics (Quirynen et al., 1995).
The aim of the present systematic review was to provide a robust critical appraisal of the
evidence of the efficacy of subgingival instrumentation for the treatment of periodontitis, the
efficacy of sonic/ultrasonic/hand instruments and the efficacy of different delivery protocols for
subgingival instrumentation in terms of timing. In order to address the aim, PICOS criteria were
set as outlined in Table 1.
PICOS Question 1
In patients with periodontitis, what is the efficacy of subgingival instrumentation performed with
hand or sonic/ultrasonic instruments in comparison with supragingival instrumentation or
prophylaxis in terms of clinical and patient reported outcomes?
PICOS Question 2
PICOS Question 3
In patients with periodontitis, what is the efficacy of full mouth delivery protocols (within 24 hours)
in comparison to quadrant or sextant wise delivery of subgingival mechanical instrumentation in
terms of clinical and patient reported outcomes?
This systematic review protocol was registered in PROSPERO on 22 February 2019 with ID no.
CRD42019124887. Preferred Reporting Items for Systematic Review and Meta-Analyses
(PRISMA) guidelines were followed in reporting this review (Moher, Liberati, Tetzlaff, & Altman,
2009). A PRISMA statement is attached to follow the reporting of this systematic review
(Appendix).
Eligibility Criteria
Studies were eligible for inclusion in the review if they reported on individuals from 18 years
onward suffering from periodontitis. All forms of periodontitis were included, excluding gingivitis,
Interventions and comparisons eligible for inclusion varied according to PICOS question. PICOS
1 included nonsurgical subgingival mechanical instrumentation compared to supra-gingival
prophylaxis or instrumentation. PICOS 2 included nonsurgical subgingival instrumentation
performed with sonic/ultrasonic instruments compared to the same performed with hand
instruments or a combination of sonic/ultrasonic and hand instruments. PICOS 3 included
nonsurgical mechanical subgingival instrumentation performed with full-mouth single visit
protocols with or without time restriction compared to the same performed in multiple sessions
according to quadrant or sextant sub-division of the mouth. Studies with unclear intervention or
comparison were excluded as well as any intervention or comparison groups reporting use of
adjunctive chemical therapies (local or systemic).
Studies reporting the primary outcome of reduction in mean probing pocket depth (PD) or
secondary outcomes of number or proportion of pockets closed, changes in clinical attachment
level (CAL), and changes of percentage bleeding on probing (BOP) were included. Studies
reporting patient level of analysis or site level analysis with multilevel or GEE approaches were
included with those reporting site level analysis only excluded.
Only randomised controlled trials with at least 3 months of post treatment follow-up were eligible
for inclusion. Articles published in languages other than English were excluded due to time
constraints.
Search Methods
Preliminary electronic searches designed to locate possible review articles, narrative and
systematic were conducted to facilitate development of the electronic search strategy. The
strategy was formulated using a combination of controlled vocabulary (MeSH and free text
terms), then piloted to confirm high sensitivity over high precision in search results in order to
maintain a broad search. The search strategy used consistent terms customised according to
each database a priori and included English language restriction. The search strategy for OVID
Medline is outlined in Table 2 as an example. Electronic databases searched up to 19th March
2019 with no year restrictions included Cochrane Central Register of Controlled Trials
(CENTRAL), MEDLINE (OVID), EMBASE, SCOPUS, and LILACS. Hand searching of
bibliographies of previously published reviews were also performed. Search results from all
databases were combined and duplicates removed.
Study Selection
Titles and abstracts of all identified reports were independently screened by two reviewers (YL &
FM) based upon the inclusion/exclusion criteria. Full text reports were obtained and assessed
independently and in duplicate for studies appearing to meet the inclusion criteria or with
insufficient information in the title or abstract to confirm eligibility for inclusion then confirmed by a
third reviewer (JS). Disagreements following full text screening were resolved by discussion and if
necessary additional reviewers were consulted (CT & JD). Excel spreadsheets were created to
record information pertaining to the decision to include or exclude each article. Kappa statistic
was used to assess the reviewer agreement based upon the full text screening.
Data Management
Two reviewers (JD & CT) extracted data into specifically created excel spreadsheets which were
then double checked by an additional reviewer (JS). Data pertaining to study characteristics such
as population, interventions, comparisons, type of outcomes reported, and study conclusions
were then transferred into evidence tables to provide an overview of the included studies and
available data. All data in the excel spreadsheets were reviewed to consider appropriateness for
meta-analysis. Data were then entered into Stata (Stata Statistical Software: Release 15,
StataCorp LLC, College Station, TX, USA) in preparation for quantitative analysis.
Outcome measures
Outcomes at 3/4 months and 6/8 months following intervention were extracted. The primary
outcome was reduction of PD expressed in mm. Further consideration was given to proportion of
secondary outcomes were changes in CAL, and changes in BOP. Full mouth plaque scores were
also extracted. Patient-reported outcome measures (PROMs) were also noted together with
Data Synthesis
For continuous data (changes of PD and CAL) mean values and standard deviations were used
and analysed with weighted mean differences (WMD) and 95% confidence intervals (CIs). For
dichotomous data (BOP and pocket closure), estimates of the effect were expressed as risk ratios
(RR) and 95% CIs. The variable pocket closure was not consistently defined throughout the
included studies. In the present analysis, reported data were pooled, irrespective of the individual
case definition. Study-specific estimates were pooled with the random-effect model (DerSimonian
& Laird, 1986) and grouped according to pocket depth (all, shallow (4-6 mm) or deep (≥7 mm))
Two separate sets of analyses were performed. For PICOS questions 2 and 3, standard meta-
analyses were performed using changes reported for test and control groups, respectively. As
none of the selected RCTs addressed PICOS question 1, it was decided a posteriori to analyse
baseline and final clinical data extracted from included and relevant studies, considering these
findings to be independent of each other. Test and control arms were considered as separate
studies. Therefore, the overall effect of treatment in terms of PD reduction and proportion of
pocket closure was estimated. All analyses were performed with Stata (Stata Statistical Software:
Release 15, StataCorp LLC, College Station, TX, USA) using the functions metan and metaprop.
Statistical heterogeneity among studies was explored by the I2 index (Higgins, Thompson,
Deeks, & Altman, 2003) and Cochrane's Q statistic (p<0.1). Forest plots were used to illustrate
the outcomes of the different analyses. To illustrate expected treatment effect prediction intervals
(PI) were calculated (Borenstein, Higgins, Hedges, & Rothstein, 2017). Publication bias was
evaluated through Funnel plots (function: metafunnel) and Egger’s test for small-study effects
(Egger, Davey Smith, Schneider, & Minder, 1997).
The combined total of references obtained from the electronic search strategy customised for
each database was 13,137 citations with hand searching adding 10 citations and removal of
duplicates resulting in 5033 citations to be screened. Independent screening of titles and
abstracts resulted in 85 full text articles to be retrieved. Further screening of full text articles
resulted in 19 articles eligible for inclusion in the review. Kappa score calculated for screening
agreement was 0.93. Figure 1 summarises the screening results in the PRISMA flow diagram
showing citations resulting at each step of the screening process. The final number of studies
included in the review were 19 with 18 of those suitable for inclusion in one of a number of meta-
analysis.
The search retrieved a large number of relevant articles together with a substantial number of
irrelevant hits confirming the high sensitivity and relatively low precision of the search in
accordance with the search strategy. Numerous citations excluded were related to application of
the therapy in periodontal treatment protocols but were not designed to investigate the efficacy of
nonsurgical subgingival instrumentation. During full text screening, 66 articles were excluded
primary due to inclusion of adjunctive antimicrobial or antiseptics therapies or lack of reporting of
data relevant to this review. The reasons for exclusion together with the articles excluded are
summarised in Table 3.
Table 3. Excluded studies and reasons for exclusion (Reference list provided in Appendix).
Descriptive results
Risk of bias
Summarized results of the assessment of risk of bias are illustrated in Figure 2. One of the
included studies was judged to be at high risk of bias and 11 studies presented with some
concerns, mainly related to data analysis. Detailed information in regard to specific items in
individual studies are reported in the full evidence table (Appendix).
Figure 2 Individual and summarised assessment of risk of bias for included studies
Table 6 presents an overview of relevant studies for each PICOS question, separated by
subcategory (time of follow-up and pocket depth) and outcome. Feasibility of meta-analysis is
depicted by colour-coding. In general, analysis of the reduction of BoP was not possible due to
the lack of site-specific reporting, while patient-reported outcomes and adverse events could not
be collectively assessed due to heterogeneous and inconsistent reporting. Sub analyses by tooth
type (single-, multi-rooted) was not feasible based on the lack of data.
PICOS question 1
One randomised controlled trial (Kapellas et al., 2013) specifically addressed PICOS question 1,
i.e. the potential benefit of subgingival instrumentation over supragingival cleaning alone. In a
specific patient population, the study indicated a significant benefit in terms of percentage of
pocket closure at 3 months. Data on BOP reduction or patient-reported outcomes were not
presented.
Figure 3a. Weighted mean PD reduction and proportion of closed pockets at 6/8 months
including Funnel plots.
Analysis of initially shallow sites revealed a weighted mean PD reduction of 1.5 mm (95%CI: 1.2;
1.7 / PI: 0.3; 2.7) at 3/4 months (10 studies) and 1.6 mm (95%CI: 1.3; 1.8 / PI: 0.6; 2.5) at 6/8
months (6 studies). For initially deep sites, a weighted PD reduction of 2.6 mm (95%CI: 2.2; 3.0 /
PI: 0.7; 4.6) at 3/4 months (10 studies) and 2.6 mm (95%CI: 1.1; 3.1 / PI: 0.5; 4.7) at 6/8 months
(7 studies) was observed (Figure 3b-1 to 3b-4).
Figure 3b. Weighted mean PD reduction for shallow and deep sites at 6/8 months including
Funnel plots.
To estimate the effect of treatment on BOP, the relative reduction of patient-based scores was
calculated for studies providing the data. The weighted mean reduction of BOP scores at 3/4
months, based on 9 studies, was 56.7% ±13.9. At 6/8 months the corresponding reduction, based
on 8 studies, was 62.7% ±17.5.
PICOS question 2
Six randomised controlled trials (Ioannou et al., 2009; Laurell & Pettersson, 1988; Malali, Kadir, &
Noyan, 2012; Obeid, D'Hoore, & Bercy, 2004; Petelin, Perkič, Seme, & Gašpirc, 2015;
Wennström, Tomasi, Bertelle, & Dellasega, 2005) specifically addressed PICOS question 2, i.e.
the comparison between hand and sonic/ultrasonic instruments for subgingival treatment. Meta-
analysis was possible for PD reduction and CAL gain, but not for any of the other outcomes
considered. No significant differences were observed between treatment groups at any time point
or for different categories of initial pocket depth. Findings at 6/8 months for PD reduction and CAL
gain are illustrated in Figure 4. The Egger’s test did not reveal a significant risk of bias. One study
reported data on site-specific reduction of BOP, not identifying any significant differences
Figure 4. WMD between hand and sonic/ultrasonic instruments for PD reduction and CAL
gain at 6/8 months including Funnel plots.
PICOS question 3
Thirteen randomised controlled trials (Apatzidou & Kinane, 2004; Del Peloso Ribeiro et al., 2008;
Fonseca et al., 2015; Jervøe-Storm et al., 2006; Koshy et al., 2005; Loggner Graff, Asklöw, &
Thorstensson, 2009; Meulman et al., 2013; Predin et al., 2014; Quirynen et al., 2006; Swierkot,
Nonnenmacher, Mutters, Flores-de-Jacoby, & Mengel, 2009; Wennström et al., 2005; Zanatta et
al., 2006; Zijnge et al., 2010) specifically addressed PICOS question 3, i.e. the comparison
between quadrant-wise and full-mouth approaches for subgingival instrumentation. Meta-analysis
was possible for the outcomes PD reduction, CAL gain and pocket closure (for details, see Table
6). No significant differences were observed between treatment groups irrespective of time point
or initial pocket depth. Findings at 6/8 months for PD reduction, CAL gain and pocket closure are
illustrated in Figure 5. The Egger’s test did not reveal a significant risk of bias. Two studies
reported site-specific reduction of BOP, indicating no significant differences between treatment
groups at 3/4 (p=0.67) and 6/8 months (p=0.78) (Del Peloso Ribeiro et al., 2008; Wennström et
al., 2005). Adverse events, addressed in 5 studies, were rare (1 event in each treatment group
reported in one study (Predin et al., 2014)) with no differences between groups. Discomfort
following instrumentation was reported in 5 studies (Apatzidou & Kinane, 2004; Del Peloso
Ribeiro et al., 2008; Koshy et al., 2005; Loggner Graff et al., 2009; Wennström et al., 2005).
Again, no differences between study groups was observed. In the study by Loggner Graff and co-
workers, operators found the quadrant-wise approach less strenuous when compared to the full-
mouth protocol (Loggner Graff et al., 2009). Findings from the remaining analyses are presented
in the Appendix.
Figure 5. WMD between quadrant-wise and full-mouth approach for PD reduction and CAL
gain at 6/8 months. RR for pocket closure at 6/8 months between treatment groups. Funnel
plots included.
DISCUSSION
measures as well as frequencies of closed pockets (probing pocket depth ≤4 mm and absence of
bleeding on probing) were considered as relevant outcomes to address the research questions.
The results from this systematic review demonstrated that subgingival instrumentation is an
efficacious treatment in reducing inflammation, probing pocket depth and number of diseased
sites in patients affected by periodontitis. This effect was consistent, irrespective of the choice of
shallow sites (4-6 mm) a mean reduction of PD of 1.5 mm can be expected at 6/8 months, while
at deeper sites (≥7 mm) the mean PD reduction was estimated at 2.6 mm. In addition, an overall
proportion of pocket closure of 74% at 6/8 months was observed, combined with a mean BOP
reduction of 62%. Considering the extent of disease resolution, as measured in terms of pocket
closure, it appears that well-performed nonsurgical periodontal therapy may limit the need of
other additional/alternative treatment approaches, which may entail higher costs and patient
morbidity.
The lack of randomised clinical trials addressing PICOS question 1 may not come as a surprise,
given the ethical implications of such a study design. The only study that could be included
adopted a 3-month delay in delivering the subgingival treatment in the control group (Kapellas et
al., 2013). Other studies addressing efficacy of subgingival instrumentation were often not
randomised and/or demonstrated a high risk of bias. Thus, the best option available was
analysing longitudinal changes reported in studies identified for PICOS questions 2 and 3. We
considered different treatment arms within the RCTs as separate units, which may have
introduced weaknesses due to potential lack of independence and the inclusion of studies not
The third PICOS question focused on the comparison between the traditional quadrant-wise
treatment approaches and full-mouth approaches to nonsurgical periodontal treatment. Results
confirmed findings reported in previously published reviews (Eberhard, Jepsen, Jervøe-Storm,
Needleman, & Worthington, 2015; Lang, Tan, Krahenmann, & Zwahlen, 2008), which failed to
identify differences. It was therefore concluded that the choice of treatment delivery may be
based on patients’ preferences and other practical considerations such as medical status,
tolerance for chair time or perhaps the need for repeated sessions of oral hygiene instructions. In
this context, full-mouth approaches have been implicated with higher acute systemic
inflammatory perturbation in the immediate post-operative period (Graziani et al., 2015). The
reader should be aware that studies including adjunctive measures (e. g. antiseptic agents) were
not included in the present analysis.
Analysing outcomes by initial PD (shallow or deep) and tooth category (single or multi-rooted) is
in line with then new classification of periodontitis (Papapanou et al., 2018). Thus, cases
classified as stage 1 or 2 are characterised by the presence of shallow pockets (≤5 mm), while
stages 3 and 4 are characterised by deep probing and furcation involvement. Although not
perfectly aligned in terms of thresholds for pocket depths, the present review showed that in more
advanced cases, nonsurgical therapy was shown to be more efficacious in terms of PD reduction,
while disease resolution, as measured by pocket closure, was less likely. Studies included in the
The primary variable chosen to evaluate treatment outcome was probing pocket depth reduction,
which is a common choice in meta-analytical approaches. Probing pocket depth serves as a
surrogate outcome variable and has been validated by its association with disease progression
and tooth loss (Badersten, Nilveus, & Egelberg, 1990; Claffey & Egelberg, 1995; Lang et al.,
2008; Matuliene et al., 2008; Westfelt, Rylander, Dahlen, & Lindhe, 1998). The goal of therapy,
however, is to obtain shallow probing pocket depth and absence of bleeding, indicating sufficient
removal of biofilm/calculus and subsequent resolution of the inflammatory lesion. Therefore, the
present review considered pocket closure as an important component to evaluate treatment
efficacy. The parameter, however, was not consistently reported and defined in different ways,
i.e. with or without the measure of BOP. Future research should highlight the frequency of pocket
closure.
The follow-up in the included studies rarely extended beyond 6 months, which may be considered
short. It should be remembered, however, that nonsurgical therapy is part of an overall treatment
strategy, constituted from many different phases, each of them needing a clinical evaluation at an
appropriate follow-up interval after its completion (Kieser, 1994). In addition, there was an
obvious variation between studies in terms of (i) follow-up, (ii) treatment strategy, (iii) self-
performed infection control and (iv) distribution of modifying factors. However, the questions
highlighted in the present review were addressed by direct comparisons within studies adapting
consistent study protocols. Thus, meta-analyses were based on differences between groups.
The external validity of the data reported in the studies included in the present review may be
discussed. While the overall risk of bias was found to be low for the vast majority of studies, most
were institutional, performed in well-controlled environments and patient samples. Therefore, the
present review probably describes efficacy rather than effectiveness of the intervention. It should
also be noted that some studies were designed to investigate different primary outcomes than
those addressed in the PICOS questions. The reader should also be aware that several of the
relevant studies were conducted prior to the development of instruments available today, i.e. thin
ultrasonic tips, micro/mini curettes). Finally, few data on adverse events or patient-reported
outcomes are presently available. Some studies with short-term patient-reported outcomes were
excluded from the review due to the inclusion criteria of 6-month follow-up. Additional limitations
of the present review are evident. For PICOS question 1, as already discussed above, baseline
In conclusion and within the limitations of the present review, a comprehensive search and
analysis of the available literature based on randomised controlled trials with a 6-month follow-up
demonstrated that mechanical subgingival instrumentation is efficacious in the nonsurgical
treatment of periodontitis, irrespective of type of instrument or mode of delivery.
ACKNOWLEDGEMENTS
The authors would like to acknowledge and thank the UCL Eastman Dental Institute librarian, Dr
Debora Marletta, for her valuable help with developing the search strategy and conduct of the
electronic database search.
CONFLICT OF INTEREST
The authors declare no conflict of interest in regard to the present work. There were no external
sources of funding to support conduct of this review.
CLINICAL RELEVANCE
Scientific rationale for the study: This systematic review provides an evidence summary of the
efficacy of subgingival instrumentation, of sonic/ultrasonic/hand instruments and of different
delivery timings in periodontitis treatment.
Principal findings: Weighted mean proportion of pocket closure was 74%. Nonsurgical
mechanical subgingival instrumentation is efficacious in achieving infection control in
periodontitis patients irrespective of whether performed by sonic/ultrasonic/hand instrument or
delivered full mouth within 24 hours or in segments over multiple visits.
Practical implications: Clinicians should consider subgingival instrumentation as a key part of
periodontal therapy and may choose instrument type and mode of delivery on an individual
patient basis.
South America 4 Zanatta et al. 2006, Del Peloso Ribeiro et al. 2008, Meulman et al. 2013,
Fonseca et al. 2015
Setting
University
16 Laurell & Pettersson 1988, Apatzidou & Kinane 2004, Obeid et al. 2004, Koshy
et al. 2005, Jervøe-Storm et al. 2006, Quirynen et al. 2006, Zanatta et al. 2006,
Del Peloso Ribeiro et al. 2008, Swierkot et al. 2009, Ioannou et al. 2009,
Loggner Graf et al. 2009, Malali et al. 2012, Meulman et al. 2013, Predin et al.
2014, Fonseca et al. 2015, Petelin et al. 2015
Public
1 Kapellas et al. 2013
Year of Publication
1988-2000
1 Laurell & Pettersson 1988
2001-2010
12 Apatzidou & Kinane 2004, Obeid et al. 2004, Wennström et al. 2005, Koshy et
al. 2005, Jervøe-Storm et al. 2006, Quirynen et al. 2006, Zanatta et al. 2006,
Del Peloso Ribeiro et al. 2008, Swierkot et al. 2009, Ioannou et al. 2009,
Loggner Graf et al. 2009, Zijnge et al. 2010
2011-Present
6 Malali et al. 2012, Meulman et al. 2013, Kapellas et al. 2013, Predin et al.
2014, Fonseca et al. 2015, Petelin et al. 2015
Table 5. Evidence Table of PICOS Characteristics of Included Studies.
Apatzidou & Kinane, (2004) Setting: University (single center) RCT Design: Parallel PICOS: 1 and 3 Pico 1: clinical benefit of
subgingival instrumentation
Scotland N = 40 Test: FM-SRP performed on the same day Values reported:
with a combination of hand and ultrasonic Mean PPD reduction Pico 2: n/a
Quadrant root planing versus Age: 31 - 70 years instruments Mean CAL gain
same-day full-mouth root Full-mouth BOP reduction Pico 3: no difference between
planing. I. Clinical findings Gender: Female n=17 Male n=23 Control: Q-SRP one hour per quadrant Pocket closure (PPD <5 mm) full mouth and quadrant
with hand and ultrasonic instruments Full-mouth plaque score approach
Smoking status: n=15 smokers
Teeth included: Reported for:
Periodontal disease status: Single and multi-rooted All sites ≥5 mm
Moderate to severe
At 13 weeks, retreatment of sites with PD Other Outcomes:
VAS scale of patient comfort
≥5 mm & BOP.
Timepoints: 6 months
Obeid et al. Setting: University (single center) RCT Design: Split mouth PICOS: 1 and 2 Pico 1: clinical benefit of
(2004) subgingival instrumentation
N = 20 Test: UD (2 minutes/tooth) ultrasonic Values reported:
Belgium Mean PPD reduction Pico 2: no difference between
Age: 40 - 69 years Control: SRP (3 minutes/tooth) hand Mean CAL gain hand and ultrasonic
Comparative clinical instruments Full-mouth BOP reduction instruments
responses related to the use Gender: Female n=10 Male n=10 Pocket closure (PPD 5 mm)
of various periodontal Teeth included: Pico 3: n/a
instrumentation Smoking status: n=4 smokers Single and multi-rooted Reported for:
All sites
Periodontal disease status: 4 treatment groups (only 2 considered). 6 Shallow sites 3-5 mm
Moderate to severe chronic periodontitis, 2 months duration. Recall at 1 month for Deep sites ≥6 mm
OHI.
molars and 3 sites single rooted PPD ≥4 mm in Other Outcomes:
each quadrant Not reported
Timepoints: 6 months
Wennström et al. Setting: University (Sweden) & private practice RCT Design: Parallel PICOS: 1, 2, and 3 Pico 1: clinical benefit of
(2005) (Italy) subgingival instrumentation
Test: Full mouth debridement with 1 hour Values reported:
Sweden & Italy N = 41 time limit with ultrasonic instrument Mean PPD reduction Pico 2: no difference between
Mean CAL gain hand and ultrasonic
Full mouth ultrasonic Age: 25 - 75 years Control: Quadrant SRP without time limit Full-mouth BOP reduction instruments
debridement versus quadrant with hand instruments Pocket closure (PPD 4 mm)
scaling and root planing as an Gender: Female n=19 Male n=22 Full-mouth plaque score Pico 3: no difference between
initial approach in the Teeth included: full mouth and quadrant
treatment of chronic Smoking status: n=20 smokers Single and multi-rooted Reported for: approach
periodontitis All sites ≥5 mm
Periodontal disease status: At 3 months, retreatment of sites with PPD Shallow sites 5-6 mm
Moderate to severe Deep sites ≥7 mm
≥5 mm.
Other Outcomes:
VAS scale of patient comfort
Root sensitivity ≥5 days post-treatment
Number of adverse events
Other Outcomes:
Not reported
Timepoints: 8 months
Zanatta et al. Setting: University (single center) RCT Design: Parallel PICOS: 1 and 3 Pico 1: clinical benefit of
(2006) subgingival instrumentation
N = 25 Test: FMS (45 minutes) ultrasonic Values reported:
Brazil Mean reduction PPD Pico 2: n/a
Age: 27 - 62 years Control: Q-SRP (no time limit) hand Mean reduction CAL
Periodontal debridement with instruments Full-mouth bleeding score Pico 3: no difference between
povidone-iodine in periodontal Gender: not specified full mouth and quadrant
treatment: short-term clinical Teeth included: Reported for: approach
and biochemical observations Smoking status: not specified Single and multi-rooted All sites ≥5 mm
Shallow sites 5-6 mm
Periodontal disease status: 3 treatment groups (only 2 considered) Deep sites ≥7 mm
Moderate Oral hygiene reinforcement and
supragingival polishing twice-weekly Other Outcomes:
during study period Not reported
Timepoints: 3 months
Ioannou et al. Setting: University (single center) RCT Design: Parallel PICOS: 1 and 2 Pico 1: clinical benefit of
(2009) subgingival instrumentation
N = 33 Test: Q-UD (3-4 sessions, no time Values reported:
Greece restriction) ultra Mean reduction PPD Pico 2: no difference between
Age: 33 – 68 years Mean reduction CAL hand instruments and
Hand instrumentation versus Control: Q-SRP (3-4 sessions, no time Full-mouth plaque score ultrasonic according to authors
ultrasonic debridement in the Gender: Female n=20 Male n=13 restriction) control
treatment of chronic Reported for: Pico 3: n/a
periodontitis: a randomized Smoking status: 51% smokers Teeth included: All sites
clinical and microbiological Single and multi-rooted Shallow sites 4-6 mm
trial Periodontal disease status: Deep sites >6 mm
Advanced chronic periodontitis: ≥4 sites with No retreatment.
Other Outcomes:
PPD ≥5 mm and BOP in at least two quadrants. Not reported
Furcation excluded.
Timepoints: 3 and 6 months
with PPD ≥5 mm and BOP 3 treatment groups (only 2 considered) Other Outcomes:
No retreatment. Number of adverse events
Zijnge et al. Setting: Private dental practice (single center) RCT Design: Parallel PICOS: 1 and 3 Pico 1: clinical benefit of
(2010) subgingival instrumentation
N = 38 Test: FM-SRP (3 hours) hand instruments Values reported:
Netherlands Mean reduction PPD Pico 2: n/a
Age: 25 – 75 years Control: Q-SRP (1 hour per quadrant) Full-mouth BOP reduction
The recolonization hypothesis hand instruments Pocket closure (PPD <3 mm when Pico 3: no difference between
in a full-mouth or multiple- Gender: Female n=16 Male n=22 full mouth and quadrant
session treatment protocol: a Teeth included: initial PPD was ≥5 mm) approach
blinded, randomized clinical Smoking status: n=0 smokers Single and multi-rooted Full-mouth plaque score
trial
Periodontal disease status: Chronic No retreatment. Reported for:
All sites ≥4 mm
periodontitis, >10% sites with PPD ≥6 mm Shallow sites 4-6 mm
Deep sites ≥7 mm
Other Outcomes:
Number of adverse events
Timepoints: 3 months
Author, year, country, Study Findings
Population of study Treatment Groups Treatment Outcomes
title
Malali et al. Setting: University (single center) RCT Design: Parallel PICOS: 1 and 2 Pico 1: clinical benefit of
(2012) subgingival instrumentation
N = 20 Test: UD (4 to 6 sessions) ultrasonic Values reported:
Turkey instruments only Mean reduction PPD Pico 2: no difference between
Age: Not specified Mean reduction CAL hand and ultrasonic
Er:YAG lasers versus Control: SRP (4 to 6 sessions) hand Full-mouth BOP reduction instruments
ultrasonic and hand Gender: Not specified instruments only Full-mouth plaque score
instruments in periodontal Pico 3: n/a
therapy: clinical parameters, Smoking status: n=0 smokers Teeth included: Reported for:
intracrevicular micro-organism Single and multi-rooted All sites
and leukocyte counts Periodontal disease status: Shallow sites 4-6 mm
Chronic periodontitis, ≥2 sites with PPD 4-6 mm 3 treatment groups (only 2 considered). Deep sites ≥7 mm
No retreatment.
and ≥2 sites with PPD ≥7 mm with BOP and Other Outcomes:
mobility 0-2 Not reported
Timepoints: 3 months
Kapellas et al. Setting: Public dental clinics (multiple clinical RCT Design: Parallel PICOS: 1 Pico 1: clinical benefit of
(2013) centers) subgingival instrumentation
Test: SRP (1 session, no time limit) hand Values reported:
Australia N = 169 and ultra Pocket closure (PPD <4 mm) Pico 2: n/a
Full-mouth plaque score
Effects of full-mouth scaling on Age: Mean age of 40 Control: no treatment Pico 3: n/a
the periodontal health of Reported for:
Indigenous Australians: a Gender: Female n=62 Male n=107 Teeth included: All sites ≥4 mm
randomized controlled trial Single and multi-rooted
Smoking status: n=87 smokers Other Outcomes:
No retreatment. Number of adverse events
Periodontal disease status:
Chronic Periodontitis, ≥2 proximal sites with CAL Timepoints: 3 months
≥4 mm or with PPD ≥5 mm
Meulman et al. Setting: University (single center) RCT Design: Parallel PICOS: 1 and 3 Pico 1: clinical benefit of
(2013) subgingival instrumentation
N = 20 Test: FMUD (1 session 45 minutes) Values reported:
Brazil ultrasonic instruments only Mean reduction PPD Pico 2: n/a
Age: Mean age of 43 years Mean reduction CAL
One stage, full-mouth, Control: Q-SRP (1 week interval) hand Full-mouth BOP reduction Pico 3: no difference between
ultrasonic debridement in the Gender: Female n=9 Male n=11 instruments only Pocket closure (PPD <5 mm and no full mouth and quadrant
treatment of severe chronic BoP) approach
periodontitis in smokers: a Smoking status: n=20 smokers (≥5 pack years) Teeth included: Full-mouth plaque score
preliminary, blind and Single and multi-rooted
randomized clinical trial Reported for:
Periodontal disease status:
3 treatment groups (only 2 considered) All sites
Severe chronic periodontitis, ≥9 teeth with PPD Monthly recall for SPT.
≥5 mm and BOP Other Outcomes:
Not reported
Timepoints: 3 and 6 months
Timepoints: 3 months
Fonseca et al. Setting: University (2 clinical centers) RCT Design: Parallel PICOS: 1 and 3 Pico 1: clinical benefit of
(2015) subgingival instrumentation
N = 28 Test: FM-SRP (2x1 hour within 24 hours) Values reported:
Brazil hand instruments Mean reduction PPD Pico 2: n/a
Age: Not specified Mean reduction CAL
Clinical and microbiologic Control: Q-SRP (30 minutes per Pocket closure (PD <4 mm when CAL Pico 3: no difference between
evaluation of scaling and root Gender: Not specified quadrant) hand instruments 3 mm) full mouth and quadrant
planing per quadrant and one- Full-mouth plaque score approach
stage full-mouth disinfection Smoking status: Not specified Teeth included:
associated with azithromycin Single and multi-rooted Reported for:
or chlorhexidine: a clinical Periodontal disease status: All sites
randomized controlled trial Mild/moderate 6 treatment groups (only 2 considered) Shallow sites 4-5 mm
No retreatment Deep sites ≥6 mm
Other Outcomes:
Not reported
jcpe_13245_f1.png
Accepted Article L L L L L L
Wennström et al. 2005
2013 C C L
Apatzidou & Kinane 2004 L C L C L C
et al. 2010
Jervøe-Storm et al. 2006 CL L L L L L
C C L
Koshy et al .2005 L L L L L L
C C L
Quirynen et al. 2006 CL C L L L C
Missing data
Randomisation
Overall risk
Selective
reporting
jcpe_13245_f2b.png
jcpe_13245_f3a-1.png
jcpe_13245_f3a-2.png
jcpe_13245_f3a-3.tif
jcpe_13245_f3a-4.png
jcpe_13245_f3b-1.tif
jcpe_13245_f3b-2.png
jcpe_13245_f3b-3.tif
jcpe_13245_f3b-4.png
jcpe_13245_f4-1.jpeg
jcpe_13245_f4-2.png
jcpe_13245_f4-3.jpeg
jcpe_13245_f4-4.png
jcpe_13245_f5-1.tif
jcpe_13245_f5-2.png
jcpe_13245_f5-3.tif
jcpe_13245_f5-4.png
jcpe_13245_f5-5.tif
jcpe_13245_f5-6.png